Complications in Reverse Shoulder Arthroplasty: Focus on Comorbidities

  • Roberto LeoEmail author
  • Valentina Fogliata
  • Bruno Michele Marelli


The number of RSA (reverse shoulder arthroplasty) implants is greatly increasing, along with the growing age of the population. Consequently, it can be argued that the population we are dealing with will have an increasing number of pathologies that can be considered as comorbidities and must be carefully pondered. Knowledge of comorbidities is therefore useful in assessing the risk/benefit ratio in the treatment of shoulder arthropathy.

For this reason, we believe it is essential to have an accurate preoperative medical history with a careful evaluation of the patient in order to proceed toward the correct decision-making process.


Comorbidities Shoulder Arthroplasty Reverse RSA 


  1. 1.
    Feinstein AR. The pre-therapeutic classification of co-morbidity in chronic disease. J Chronic Dis. 1970;23(7):455–68.CrossRefGoogle Scholar
  2. 2.
    Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–83.CrossRefGoogle Scholar
  3. 3.
    Voskuijl T, Hageman M, Ring D. Higher Charlson Comorbidity Index Scores are associated with readmission after orthopaedic surgery. Clin Orthop Relat Res. 2014;472(5):1638–44. Scholar
  4. 4.
    Singh JA, Sperling JW, Cofield RH. Ninety day mortality and its predictors after primary shoulder arthroplasty: an analysis of 4,019 patients from 1976-2008. BMC Musculoskelet Disord. 2011;12(12):231. Scholar
  5. 5.
    Chalmers PN, Gupta AK, Rahman Z, Bruce B, Romeo AA, Nicholson GP. Predictors of early complications of total shoulder arthroplasty. J Arthroplast. 2014;29(4):856–60. Scholar
  6. 6.
    Dripps RD. New classification of physical status. Anesthesiol. 1963;24:111.Google Scholar
  7. 7.
    American Society of Anesthesiologists (ASA). ASA Physical Status Classification System. [Online].
  8. 8.
    Ricchetti ET, Abboud JA, Kuntz AF, Ramsey ML, Glaser DL, Williams GR Jr. Total shoulder arthroplasty in older patients: increased perioperative morbidity? Clin Orthop Relat Res. 2011;469(4):1042–9. Scholar
  9. 9.
    Dunn JC, Lanzi J, Kusnezov N, Bader J, Waterman BR, Belmont PJ Jr. Predictors of length of stay after elective total shoulder arthroplasty in the United States. J Shoulder Elbow Surg. 2015;24(5):754–9. Scholar
  10. 10.
    Shields E, Iannuzzi JC, Thorsness R, Noyes K, Voloshin I. Postoperative morbidity by procedure and patient factors influencing major complications within 30 days following shoulder surgery. Orthop J Sports Med. 2014;2(10):2325967114553164. eCollection 2014 OctCrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Singh JA, Sperling JW, Schleck C, Harmsen WS, Cofield RH. Periprosthetic infections after total shoulder arthroplasty: a 33-year perspective. J Shoulder Elb Surg. 2012;21(11):1534–41. Scholar
  12. 12.
    Farng E, Zingmond D, Krenek L, Soohoo NF. Factors predicting complication rates after primary shoulder arthroplasty. J Shoulder Elb Surg. 2011;20(4):557–63. Scholar
  13. 13.
    Davis DE, Paxton ES, Maltenfort M, Abboud J. Factors affecting hospital charges after total shoulder arthroplasty: an evaluation of the National Inpatient Sample database. J Shoulder Elb Surg. 2014;23(12):1860–6. Scholar
  14. 14.
    Singh JA, Sperling JW, Cofield RH. Cardiopulmonary complications after primary shoulder arthroplasty: a cohort study. Semin Arthritis Rheum. 2012;41(5):689–97. Scholar
  15. 15.
    Davis JM 3rd, Matteson EL, American College of Rheumatology; European League Against Rheumatism. My treatment approach to rheumatoid arthritis. Mayo Clin Proc. 2012;87(7):659–73. Scholar
  16. 16.
    Cuomo F, Greller MJ, Zuckerman JD. The rheumatoid shoulder. Rheum Dis Clin N Am. 1998;24(1):67–82.CrossRefGoogle Scholar
  17. 17.
    Weiss JJ, Thompson GR, Doust V, Burgener F. Rotator cuff tears in rheumatoid arthritis. Arch Intern Med. 1975;135(4):521–5.CrossRefGoogle Scholar
  18. 18.
    Germano V, Cattaruzza MS, Osborn J, Tarantino A, Di Rosa R, Salemi S, D’Amelio R. Infection risk in rheumatoid arthritis and spondyloarthropathy patients under treatment with DMARDs, corticosteroids and TNF-α antagonists. J Transl Med. 2014;12:77. Scholar
  19. 19.
    Marchant MH Jr, Viens NA, Cook C, Vail TP, Bolognesi MP. The impact of glycemic control and diabetes mellitus on perioperative outcomes after total joint arthroplasty. J Bone Joint Surg Am. 2009;91(7):1621–9. Scholar
  20. 20.
    Jain NB, Guller U, Pietrobon R, Bond TK, Higgins LD. Comorbidities increase complication rates in patients having arthroplasty. Clin Orthop Relat Res. 2005;435:232–8.CrossRefGoogle Scholar
  21. 21.
    Ponce BA, Menendez ME, Oladeji LO, Soldado F. Diabetes as a risk factor for poorer early postoperative outcomes after shoulder arthroplasty. J Shoulder Elb Surg. 2014;23(5):671–8. Scholar
  22. 22.
    Toor AS, Jiang JJ, Shi LL, Koh JL. Comparison of perioperative complications after total elbow arthroplasty in patients with and without diabetes. J Shoulder Elb Surg. 2014;23(11):1599–606. Scholar
  23. 23.
    Hemmingsen B, Lund SS, Gluud C, Vaag A, Almdal T, Hemmingsen C, Wetterslev J. Targeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitus. Cochrane Database Syst Rev. 2011;6:CD008143. Scholar
  24. 24.
    Moutschen MP, Scheen AJ, Lefebvre PJ. Impaired immune responses in diabetes mellitus: analysis of the factors and mechanisms involved. Relevance to the increased susceptibility of diabetic patients to specific infections. Diabete Metab. 1992;18(3):187–201.PubMedGoogle Scholar
  25. 25.
    Rask-Madsen C, King GL. Vascular complications of diabetes: mechanisms of injury and protective factors. Cell Metab. 2013;17(1):20–33. Scholar
  26. 26.
    Bolognesi MP, Marchant MH Jr, Viens NA, Cook C, Pietrobon R, Vail TP. The impact of diabetes on perioperative patient outcomes after total hip and total knee arthroplasty in the United States. J Arthroplast. 2008;23(6 Suppl 1):92–8. Scholar
  27. 27.
    Soohoo NF, Farng E, Lieberman JR, Chambers L, Zingmond DS. Factors that predict short-term complication rates after total hip arthroplasty. Clin Orthop Relat Res. 2010;468(9):2363–71. Scholar
  28. 28.
    Beck JD, Irgit KS, Andreychik CM, Maloney PJ, Tang X, Harter GD. Reverse total shoulder arthroplasty in obese patients. J Hand Surg Am. 2013;38(5):965–70. Scholar
  29. 29.
    Garcia GH, Fu MC, Dines DM, Craig EV, Gulotta LV. Malnutrition: a marker for increased complications, mortality, and length of stay after total shoulder arthroplasty. J Shoulder Elb Surg. 2016;25(2):193–200. Scholar
  30. 30.
    Anwar J, Mpofu E, Matthews LR, Shadoul AF, Brock KE. Reproductive health and access to healthcare facilities: risk factors for depression and anxiety in women with an earthquake experience. BMC Public Health. 2011;11:523. Scholar
  31. 31.
    Linton SJ, Halldén K. Can we screen for problematic back pain? A screening questionnaire for predicting outcome in acute and subacute back pain. Clin J Pain. 1998;14(3):209–15.CrossRefGoogle Scholar
  32. 32.
    Linton SJ. A review of psychological risk factors in back and neck pain. Spine (Phila Pa 1976). 2000;25(9):1148–56.CrossRefGoogle Scholar
  33. 33.
    Magni G, Marchetti M, Moreschi C, Merskey H, Luchini SR. Chronic musculoskeletal pain and depressive symptoms in the National Health and Nutrition Examination. I. Epidemiologic follow-up study. Pain. 1993;53(2):163–8.CrossRefGoogle Scholar
  34. 34.
    Magni G, Moreschi C, Rigatti-Luchini S, Merskey H. Prospective study on the relationship between depressive symptoms and chronic musculoskeletal pain. Pain. 1994;56(3):289–97.CrossRefGoogle Scholar
  35. 35.
    Bilberg R, Nørgaard B, Overgaard S, Roessler KK. Patient anxiety and concern as predictors for the perceived quality of treatment and patient reported outcome (PRO) in orthopaedic surgery. BMC Health Serv Res. 2012;12:244. Scholar
  36. 36.
    Bot AG, Menendez ME, Neuhaus V, Ring D. The influence of psychiatric comorbidity on perioperative outcomes after shoulder arthroplasty. J Shoulder Elb Surg. 2014;23(4):519–27. Scholar
  37. 37.
    Fisher DA, Dierckman B, Watts MR, Davis K. Looks good but feels bad: factors that contribute to poor results after total knee arthroplasty. J Arthroplast. 2007;22(6 Suppl 2):39–42.CrossRefGoogle Scholar
  38. 38.
    Ring D, Kadzielski J, Fabian L, Zurakowski D, Malhotra LR, Jupiter JB. Self-reported upper extremity health status correlates with depression. J Bone Joint Surg Am. 2006;88(9):1983–8.PubMedGoogle Scholar
  39. 39.
    Vissers MM, de Groot IB, Reijman M, Bussmann JB, Stam HJ, Verhaar JA. Functional capacity and actual daily activity do not contribute to patient satisfaction after total knee arthroplasty. BMC Musculoskelet Disord. 2010;11:121. Scholar
  40. 40.
    Vranceanu AM, Jupiter JB, Mudgal CS, Ring D. Predictors of pain intensity and disability after minor hand surgery. J Hand Surg Am. 2010;35(6):956–60. Scholar
  41. 41.
    Kowal SL, Dall TM, Chakrabarti R, Storm MV, Jain A. The current and projected economic burden of Parkinson’s disease in the United States. Mov Disord. 2013;28(3):311–8. Scholar
  42. 42.
    Leibson CL, Maraganore DM, Bower JH, Ransom JE, O’brien PC, Rocca WA. Comorbid conditions associated with Parkinson’s disease: a population-based study. Mov Disord. 2006;21(4):446–55.CrossRefGoogle Scholar
  43. 43.
    Burrus MT, Werner BC, Cancienne JM, Gwathmey FW, Brockmeier SF. Shoulder arthroplasty in patients with Parkinson’s disease is associated with increased complications. J Shoulder Elb Surg. 2015;24(12):1881–7. Scholar
  44. 44.
    Koch LD, Cofield RH, Ahlskog JE. Total shoulder arthroplasty in patients with Parkinson’s disease. J Shoulder Elb Surg. 1997;6(1):24–8.CrossRefGoogle Scholar
  45. 45.
    Kryzak TJ, Sperling JW, Schleck CD, Cofield RH. Total shoulder arthroplasty in patients with Parkinson’s disease. J Shoulder Elb Surg. 2009;18(1):96–9. Scholar
  46. 46.
    Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science. 1989;244(4902):359–62.CrossRefGoogle Scholar
  47. 47.
    Kuo G, Choo QL, Alter HJ, Gitnick GL, Redeker AG, Purcell RH, Miyamura T, Dienstag JL, Alter MJ, Stevens CE, et al. An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science. 1989;244(4902):362–4.CrossRefGoogle Scholar
  48. 48.
    Rosas S, Sabeh KG, Buller LT, Law TY, Kalandiak SP, Levy JC. Comorbidity effects on shoulder arthroplasty costs analysis of a nationwide private payer insurance data set. J Shoulder Elb Surg. 2017;26(7):e216–21. Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  • Roberto Leo
    • 1
    Email author
  • Valentina Fogliata
    • 1
  • Bruno Michele Marelli
    • 2
  1. 1.UOS Chirurgia della Spalla e del GomitoCentro Specialistico Ortopedico Traumatologico Gaetano Pini-CTOMilanItaly
  2. 2.UOC Ortopedia e Traumatologia 1Centro Specialistico Ortopedico Traumatologico Gaetano Pini-CTOMilanItaly

Personalised recommendations